Connect with us
The international cannabis industry is shifting, with North America facing pricing and regulatory challenges while Europe, especially medical cannabis, becomes a key growth region. Tilray Brands...
In March 2026, Aurora exited the recreational cannabis market to focus on higher-margin global medical cannabis. With 81% of revenue from medical sales, growth is driven...
Tilray’s Q3 2025 results show $186 million in revenue, down year-over-year, with a reduced full-year forecast of $850–900 million. While margins in its cannabis division rose...
Aurora Cannabis faces market pressure despite strong international sales and record recent results. Its cautious 2026 outlook makes the stock speculative and suited for risk-tolerant investors....
Canopy Growth shares rose 8.3% to CAD 1.82 but remain far below their 52-week high. The company reported weak financials, including a CAD -1.43 loss per...
On Wednesday, December 22nd, 2021, the Canadian company - which also grows outdoor cannabis on a large scale in South Africa, perhaps because of the sunnier...